ABX464 in Phase 2a Trials for RA Michele B. Kaufman, PharmD, BCGP | June 29, 2020Research is examining the safety and tolerability of two different doses of ABX464 in patients with moderate to severe active RA…
Abx464 Enters Phase 2 Clinical Trials for RA in Europe Michele B. Kaufman, PharmD, BCGP | September 30, 2019In Europe, researchers are evaluating the safety, tolerability and efficacy of ABX464 in rheumatoid arthritis patients…